Back to results
US 2003/0167006 A1Published application
Ultrasound contrast using halogenated xanthenes
AssigneeXantech Pharmaceuticals, Inc.
InventorsH. Craig Dees, Timothy C. Scott, Eric A. Wachler
Life of this patent
Estimating the term…
Abstract
New contrast agents for ultrasound imaging and methods for use of such agents for imaging of human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene or halogenated xanthene derivative. Preferably, the halogenated xanthene is Rose Bengal or a functional derivative of Rose Bengal.
Claims6
A method for imaging human or animal tissue comprising the steps of:
- administering an ultrasound contrast agent to a patient, a portion of said ultrasound contrast agent being retained in tissue of interest;
- and
- imaging said tissue with ultrasound to identify said tissue,
- wherein said ultrasound contrast agent is a halogenated xanthene.
1 more element
A medicament comprising at least one halogenated xanthene as a primary active component, wherein said medicament is useful for ultrasound imaging of human and animal tissue.
Dependencies are inferred from the claim text.